The present invention is directed to novel substituted aminotetrahydropyrans of structural formula I which are inhibitors of the dipeptidyl peptidase-IV enzyme and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly Type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved.
                            本发明涉及结构式I的新型取代
氨基
四氢吡喃衍
生物,其是
二肽基肽酶IV酶的
抑制剂,并且在治疗或预防涉及
二肽基肽酶IV酶的疾病,例如糖尿病和特别是2型糖尿病中有用。本发明还涉及包含这些化合物的药物组合物以及在预防或治疗涉及
二肽基肽酶IV酶的这些疾病中使用这些化合物和组合物。